Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Total elbow replacement can be a valuable option for the treatment of the elbow in haemophilia where there are associated arthropathic changes. We describe the outcome of seven elbow replacements in five consecutive patients with severe haemophilia A (native factor levels < 1%) at a mean of 42 months (25 to 65) after operation. All the patients had excellent relief of pain and improvement in function. One failure was due to infection in an immunocompromised patient with both HIV and Hepatitis C antibodies who was on anti-retroviral chemotherapy. The implant was revised at 30 months in a one-stage procedure and showed no evidence of loosening or infection 35 months later.

Original publication

DOI

10.1302/0301-620x.85b8.13986

Type

Journal article

Journal

J Bone Joint Surg Br

Publication Date

11/2003

Volume

85

Pages

1138 - 1140

Keywords

Adult, Arthroplasty, Replacement, Elbow Joint, Hemophilia A, Humans, Middle Aged, Pain Measurement, Postoperative Complications, Prosthesis Failure, Radiography, Range of Motion, Articular, Reoperation, Treatment Outcome